AzTrials
AzTrials

Opioid-Related DisordersNCT03022890

Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy

A study testing hatha yoga and health education in people with Opioid-Related Disorders and Pain, Chronic, run by Butler Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Specific Aims of this treatment development research are: To conduct a pilot randomized clinical trial (n = 40) of hatha yoga vs. a health education group (attention control) for persons with chronic pain who are taking methadone maintenance therapy (MMT) or bupreonorphine (BUP) for opioid use disorder maintenance… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Opioid-Related Disorders, Pain, Chronic
What is being tested?
hatha yoga and health education
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
1 Apr 2017to 1 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Enrolled in methadone maintenance treatment or buprenorphine treatment for 3 or more months;
  • Plan to continue this treatment for next 6 months;
  • Chronic pain, defined as pain duration for at least three months (Dworkin et al., 2012), a mean score of 4 or higher on the BPI Pain Interference Scale (C. S. Cleeland \& Ryan, 1994), and pain severity of 4 or higher on a Visual Analog Scale (0-10) indicating "worst pain in the last week"(Breivik et al., 2008; Jensen, Chen, \& Brugger, 2003);
  • No current psychosis;
  • Do not anticipate have surgery in the next 6 months;
  • Not currently taking yoga classes, not practicing yoga once per week or more often at home;
Show all 11Show fewer
  • Not engaging in meditation once per week or more often;
  • Medically cleared by a primary care physician or SSTAR's OAT physician for mild-moderate physical activity (this is the only criterion NOT required for Phase 1 participants);
  • Not pregnant;
  • Aged 18 or older;
  • Proficiency in English sufficient to engage in informed consent in English and understand classes taught in English.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanley Street Treatment and Resources

    Fall River, Massachusetts, 02720

Other trials in United States

About this study

Official title: Pilot Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy

The Specific Aims of this treatment development research are:

To conduct a pilot randomized clinical trial (n = 40) of hatha yoga vs. a health education group (attention control) for persons with chronic pain who are taking methadone maintenance therapy (MMT) or bupreonorphine (BUP) for opioid use disorder maintenance treatment. Participants will be enrolled in the active intervention for 3 months, and then be followed for 6 months afterwards. Investigators' aims are:

  1. To assess feasibility and acceptability of both the yoga class and the health education control group. Investigators will assess credibility of the assigned intervention and expectancy for improvement for both groups at baseline, program satisfaction following program participation, participant adherence (class attendance rate and amount of home practice corresponding to assigned study arm), and instructor fidelity to the manuals. Investigators will conduct structured interviews following program participation to understand specific aspects of both programs considered attractive, useful, or not useful; we will solicit suggestions for improvements as well.
  2. To assess safety, investigators will track all adverse events in a structured fashion. Investigators do not expect to see any serious adverse events definitely or probably related to study participation.
  3. To assess feasibility of research procedures, investigators have benchmarks for recruitment rate, retention for study assessments, and reliability of instructor fidelity measures.
Read the detailed description

Chronic pain is a significant problem for people receiving opioid agonist therapy (OAT) for opioid dependence - i.e., buprenorphine/ naloxone (BUP) and methadone maintenance treatment (MMT). At least half of patients receiving BUP and MMT report chronic pain. In this population, chronic pain is associated with pain-related disability, psychiatric problems, physical problems, and increased likelihood of misuse of opioids or other illicit drugs, often leading providers to terminate treatment. Several issues complicate pharmacologic pain treatment in OAT patients, including opioid-induced hyperalgesia, increased tolerance of opioids, illicit drug use, use of benzodiazepines and alcohol, and patients' own fears about medications and addiction. Further, providers may have insufficient education regarding pain management in OAT patients, and have difficulty resolving the seeming inconsistencies between a pain management approach and an addiction management approach. There are few studies of non-pharmacologic treatment approaches to pain in OAT patients. Cognitive-behavioral therapy may be efficacious for treating pain across a range of chronic pain conditions, but studies of CBT for pain relief amongst substance abusers are rare.

Hatha yoga may be a beneficial adjunctive approach to treating chronic pain, decreasing pain-related disability, and preventing opioid misuse during OAT. Hatha yoga involves breath control (pranayama), physical postures (asanas), and meditation (dhyana). Yoga includes benefits of relaxation training, physical activity, and mindfulness training in a single unified practice. Further, yoga is a non-pharmacologic approach to pain, and therefore avoids many of the problems surrounding pharmacologic treatment of chronic pain in people receiving OAT. Yoga is a promising approach for treatment of chronic pain in people enrolled in OAT because: 1) yoga has evidence supporting its ability to reduce pain-related disability and pain severity in other populations; 2) there are plausible cognitive/affective and behavioral mechanisms by which yoga may reduce chronic pain, decrease pain-related disability, and reduce opioid misuse; 3) yoga is increasingly popular and available; 4) yoga can be a complement to other types of pain and substance use treatment; 5) yoga students may like the focus on improving overall health and well-being rather than on "fixing" a problem.

Thus, the investigators propose to conduct treatment development research that would prepare us to study whether yoga (vs. a health education control group) might be an efficacious adjunctive treatment for pain in people enrolled in OAT for opioid use disorders.

The specific aims are:

To conduct a pilot randomized clinical trial (n = 40) of hatha yoga vs. a health education group (attention control) for persons with chronic pain who are taking methadone maintenance therapy (MMT) or bupreonorphine (BUP) for opioid use disorder maintenance treatment. Participants will be enrolled in the active intervention for 3 months, and then be followed for 6 months afterwards. Investigators' aims are:

  1. To assess feasibility and acceptability of both the yoga class and the health education control group. Investigators will assess credibility of the assigned intervention and expectancy for improvement for both groups at baseline, program satisfaction following program participation, participant adherence (class attendance rate and amount of home practice corresponding to assigned study arm), and instructor fidelity to the manuals. Investigators will conduct structured interviews following program participation to understand specific aspects of both programs considered attractive, useful, or not useful; we will solicit suggestions for improvements as well.
  2. To assess safety, investigators will track all adverse events in a structured fashion. Investigators do not expect to see any serious adverse events definitely or probably related to study participation.
  3. To assess feasibility of research procedures, investigators have benchmarks for recruitment rate, retention for study assessments, and reliability of instructor fidelity measures.

Investigators will use information collected from participant interviews as well as feedback from yoga and health education instructors and experts in addiction, chronic pain, and yoga to make modifications to interventions or research procedures intended to improve acceptability, feasibility, and safety whenever possible. This project will provide investigators with materials, experience, and pilot data needed for the next stage of this line of research, namely, a fully powered randomized clinical trial. Hatha yoga has a potential to decrease pain-related disability, pain severity, and opioid misuse in this population of people with difficult-to-treat chronic pain.

Being tested
hatha yoga, health education
Medical subject headings
Opioid-Related Disorders, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hatha yogaBehavioural

    12 weeks of hour-long gentle hatha yoga classes

  • health educationBehavioural

    12 weeks of hour-long classes on nutrition, sleep, coping with pain, and other health educaiton topics

Study groups in NCT03022890
Study groupRoleWhat they receive
Hatha yogaExperimental12 weeks of hatha yoga classes, once per week
Receives: Behavioral: hatha yoga
Health educationPlacebo comparator12 weeks of health education classes, once per week
Receives: Behavioral: health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Client Satisfaction Questionnaire

    satisfaction with interventions

    Measured: 3 months

  2. Credibility Expectancy Questionnaire (CEQ)

    credibility of interventions and expectancy of improvement due to interventions

    Measured: 1 month

  3. Participant adherence

    Class attendance

    Measured: 3 months

  4. Participant homework adherence

    Homework questionnaire

    Measured: 3 months

  5. Instructor manual fidelity checklist

    Measured: 3 months

  6. Systematic Assessment of Treatment-Emergent Events - General Inquiry

    used for documenting any adverse events

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2017 (estimated)
  2. Study start1 Apr 2017
  3. Primary completion16 Nov 2018
  4. Study completion1 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03022890
Sponsor's protocol ID
R34AT009432
Other IDs
R34AT009432
Status last verified
Aug 2019
First submitted
5 Jan 2017
Last updated
9 Aug 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Uebelacker LA, Van Noppen D, Tremont G, Bailey G, Abrantes A, Stein M. A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder. J Subst Abuse Treat. 2019 Oct;105:19-27. doi: 10.1016/j.jsat.2019.07.015. Epub 2019 Jul 24.

    PubMed 31443887

Questions about this trial

What is this clinical trial studying?

A study testing hatha yoga and health education in people with Opioid-Related Disorders and Pain, Chronic, run by Butler Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Client Satisfaction Questionnaire (time frame: 3 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03022890, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in